Ironwood Pharma | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 113.04 MEarnings Watch·Aug 6 at 06:17 AMIRWD+2.78%
Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results | IRWD Stock NewsStockTitan·Aug 5 at 10:05 PMIRWD+2.78%
Arrowstreet Capital Limited Partnership Has $11.92 Million Stake in Ironwood Pharmaceuticals, Inc. $IRWDMarket Beat·Aug 1 at 02:26 AMIRWD+2.78%
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 8.7% - Should You Buy?Market Beat·Jul 31 at 12:00 PMIRWD+2.78%
Ironwood Pharmaceuticals’ Jeffrey Silber, SVP and CMO, files initial beneficial ownership statementPUBT·Jul 22 at 03:05 PMIRWD+2.78%
Ironwood names Jeffrey Silber chief medical officer, succeeding Michael ShetzlinePUBT·Jul 14 at 06:30 AMIRWD+2.78%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·Jul 7 at 04:05 PMIRWD+2.78%PBYI+0.22%
Ironwood Pharmaceuticals shareholders approve 10 million-share increase to equity incentive planPUBT·Jun 18 at 03:15 PMIRWD+2.78%
Ironwood Pharma Director Julie McHugh disposes of 21,571 shares worth $80,449.83PUBT·Jun 17 at 03:42 PMIRWD+2.78%
